Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis
- PMID: 33376008
- PMCID: PMC7832677
- DOI: 10.1016/j.jfma.2020.12.003
Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis
Abstract
Background/purpose: The aim of this study was to systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes.
Methods: Included were all COVID-19 published studies between January 1 to July 20, 2020. The random effect model was used to calculate the pooled prevalence and corresponding 95% confidence interval (CI). Publication bias was assessed using the funnel plot for the standard error by logit event.
Results: The mean age of the patients was 46.8 years (95% CI, 41.0-52.6) and males comprised 54.0% (95% CI, 51.3-56.7). Total co-morbidities prevalence was 29.5% (95% CI, 19.0-36.6), with diabetes mellitus being the most prevalent 13.8% (95% CI, 8.7-21.1), followed by hypertension 11.7% (95% CI, 5.7-22.6), and cardiovascular disease 9.7% (95% CI, 6.5-14.2). The most common clinical manifestations were fever, 82.0% (95% CI, 67.7-90.8), cough 54.3% (95% CI, 45.5-62.9), fatigue 30.2% (95% CI, 23.3-38.1), sputum 28.5% (95% CI, 21.2-37.2), sore throat 21.7% (95% CI, 14.6-31.0), and headache 11.0% (95% CI, 7.9-15.2). The most common COVID-19 serious complications were RNA Anemia 98.2% (95% CI, 96.2-99.2), hospitalization 83.7% (95% CI, 76.0-89.3), bilateral pneumonia 70.9% (95% CI, 58.2-81.0); of those hospitalized 43.5% (95% CI, 24.9-64.2) were discharged. Fatality accounted for 10.5% (95% CI 6.8-16.1).
Conclusion: Patients infected with COVID-19 coronavirus showed a wide range of clinical presentation with non-specific symptoms.
Keywords: COVID-19; Clinical features; Epidemic; Meta-analysis; SARS-CoV-2.
Copyright © 2020 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no conflicts of interest relevant to this article.
Figures
References
-
- Adhikari S., Meng S., Wu Y., Yu-Ping M., Rui-Xue Y., Qing-Zhi W. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. doi: 10.1186/s40249-020-00646-x. - DOI - PMC - PubMed
-
- World Health Organization Novel coronavirus (2019-nCoV) - situation report - 10 30. January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
